Effect of aspirin on all-cause mortality in the healthy elderly

Background: In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically high...

Full description

Bibliographic Details
Main Authors: McNeil, J., Nelson, M., Woods, R., Lockery, J., Wolfe, R., Reid, Christopher, Kirpach, B., Shah, R., Ives, D., Storey, E., Ryan, J., Tonkin, A., Newman, A., Williamson, J., Margolis, K., Ernst, M., Abhayaratna, W., Stocks, N., Fitzgerald, S., Orchard, S., Trevaks, R., Beilin, L., Donnan, G., Gibbs, P., Johnston, C., Radziszewska, B., Grimm, R., Murray, A.
Format: Journal Article
Published: Massachusetts Medical Society 2018
Online Access:http://hdl.handle.net/20.500.11937/74680